Genomic DNA was isolated from whole blood using Yekta Tajhiz genomic DNA purification kit (Yekta Tajhiz, Iran). In the molecular method, the identification of
Plasmodium species was performed by amplification of 18srRNA using Nested-PCR as described in previous studies (
21). We utilized three kinds of primers to establish our diagnosis. The first one that amplified a 1200bp product (first PCR), was applied for detection of
Plasmodium sp. The other primers amplified 120bp and 205bp products (second PCR) that were applied to diagnose
P. vivax and
P. falciparum, respectively. All PCR reactions were done in a total volume of 25 μL. In brief, PCR mixture contained 100 ng of purified template DNA, 250 nM of each forward and reverse primers, 0.1 mM of each deoxynucleotide triphosphate, 1 × PCR buffer (50 mM KCl and 10 mM tris-HCl), 2.0 mM MgCl
2, and 1.25 U Taq polymerase (Yekta Tajhiz Company, Iran).
Then, the mixture was placed in a thermocycler apparatus. PCR was performed according to predetermined program. The product of the first PCR was used as a DNA template for the second PCR. This template was mixed with reaction components and specific primers of Falciparum and Vivax and PCR was run according to the protocol introduced by Snounou et al. (
21). The amplified products of the second PCR were separated on 2% agarose gel and visualized by Gel Red stain under UV illumination (
Figure 2). Positive and negative controls were used in each series of PCR assay experiments. The positive control was the DNA extracted from the blood of malaria patients, which was confirmed microscopically. Negative controls were DNA extracted from the blood of healthy individuals who had no history of malaria infection and no immigration to endemic areas of malaria.